tiprankstipranks
Trending News
More News >
Bicara Therapeutics Inc. (BCAX)
NASDAQ:BCAX
US Market

Bicara Therapeutics Inc. (BCAX) Technical Analysis

Compare
41 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
12Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
10Bearish
Bicara Therapeutics Inc.’s (BCAX) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting Bicara Therapeutics Inc. is a Buy.
Bicara Therapeutics Inc.’s (BCAX) 20-Day exponential moving average is 13.64, while Bicara Therapeutics Inc.’s (BCAX) share price is $9.27, making it a Sell.
Bicara Therapeutics Inc.’s (BCAX) 50-Day exponential moving average is 13.51, while Bicara Therapeutics Inc.’s (BCAX) share price is $9.27, making it a Sell.

Bicara Therapeutics Inc. (BCAX) Pivot Points

May 27, 2025, 05:25 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.35
13.03
14.34
15.02
16.33
17.01
18.32
Fibonacci
13.03
13.79
14.26
15.02
15.78
16.25
17.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bicara Therapeutics Inc. (BCAX) Moving Averages

May 27, 2025, 05:25 PM
Period
Simple
Exponential
MA5
13.95Sell
13.06Sell
MA10
13.96Sell
13.59Sell
MA20
13.88Sell
13.64Sell
MA50
13.04Sell
13.51Sell
MA100
13.26Sell
14.71Sell
MA200
Bicara Therapeutics Inc.’s (BCAX) 10-Day exponential moving average is 13.59, while Bicara Therapeutics Inc.’s (BCAX) share price is $9.27, making it a Sell.
Bicara Therapeutics Inc.’s (BCAX) 100-Day exponential moving average is 14.71, while Bicara Therapeutics Inc.’s (BCAX) share price is $9.27, making it a Sell.
Bicara Therapeutics Inc.’s (BCAX) stock price is $9.27 and Bicara Therapeutics Inc.’s (BCAX) 50-day simple moving average is 13.04, creating a Sell signal.
Bicara Therapeutics Inc.’s (BCAX) stock price is $9.27 and Bicara Therapeutics Inc.’s (BCAX) 100-day simple moving average is 13.26, creating a Sell signal.

Bicara Therapeutics Inc. (BCAX) Technical Indicators

May 27, 2025, 05:25 PM
Name
Value
Implied Action
RSI (14)
34.33
Neutral
STOCH (9,6)
58.85
Neutral
STOCHRSI (14)
62.53
Neutral
MACD (12,26)
0.07
Buy
ADX (14)
17.61
Buy
Williams %R
-81.56
Buy
CCI (14)
-314.96
Buy
ATR (14)
1.95
-
Ultimate Oscillator
46.62
Neutral
ROC
-33.79
Sell
Bicara Therapeutics Inc.’s (BCAX) Relative Strength Index (RSI) is 34.33, creating a Neutral signal.
Bicara Therapeutics Inc.’s (BCAX) Trend Strength Indicator (ADX) is 17.61, creating a Buy signal.
Bicara Therapeutics Inc.’s (BCAX) Commodity Channel Index (CCI) is -314.96, creating a Buy signal.
Bicara Therapeutics Inc.’s (BCAX) Price Rate of Change (ROC) is -33.79, creating a Sell signal.

FAQ

Is BCAX a Buy, Hold, or Sell?
Based on BCAX’s technical indicators, BCAX is a Sell.
    What is BCAX’s RSI (14)?
    BCAX’s RSI (14) is 34.33, which suggests BCAX is a Neutral.
      What is BCAX’s MACD?
      BCAX’s MACD is 0.07, which suggests BCAX is a Buy.
        What is BCAX’s 5-day moving average?
        BCAX’s 5-day moving average is 13.95, which suggests BCAX is a Sell.
          What is BCAX’s 20-day moving average?
          BCAX 20-day moving average is 13.88, which suggests BCAX is a Sell.
            What is BCAX’s 50-day moving average?
            BCAX’s 50-day moving average is 13.04, which suggests BCAX is a Sell.
              What is BCAX’s 200-day moving average?
              Currently, no data Available
              What is BCAX’s Williams % R (14)?
              BCAX’s Williams % R (14) is -81.56, which suggests BCAX is a Buy.
                What is BCAX’s CCI (14)?
                BCAX’s CCI (14) is -314.96, which suggests BCAX is a Buy.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis